The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2017-11-13
Summary
To observe the changes of plasma hepatocyte growth factor and soluble receptor s-Met levels in patients with sepsis, and to explore its clinical significance.
Conditions
Interventions
- OTHER
-
taking peripheral blood
taking peripheral blood of no more than 3ml
Sponsors & Collaborators
-
Jingyuan,Xu
lead OTHER
Principal Investigators
-
yi yang, doctor · Zhongda Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-09
- Primary Completion
- 2017-11-09
- Completion
- 2018-03-01
Countries
- China
Study Locations
More Related Trials
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202 ·Status: COMPLETED
-
Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis
NCT03952390 ·Status: COMPLETED
-
The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS
NCT06063707 ·Status: NOT_YET_RECRUITING
-
Serial Body Composition Change for Risk Prediction and Nutritional Guide in Treating Patients With Sepsis
NCT04989569 ·Status: COMPLETED ·Phase: NA
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis
NCT02544490 ·Status: COMPLETED
-
Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism
NCT02361970 ·Status: COMPLETED
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 ·Status: UNKNOWN
-
Hepcidin: a Prognostic Marker of Morbidity and Mortality in Severe Sepsis?
NCT03682003 ·Status: UNKNOWN
-
Inflammatory Mediators in Early Sepsis
NCT02692118 ·Status: UNKNOWN
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
NCT02883218 ·Status: COMPLETED
-
Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand
NCT02217592 ·Status: COMPLETED
-
Dissecting How Peripheral Lymphocytes Are Lost During Sepsis
NCT03289312 ·Status: UNKNOWN
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
Molecular Biomarkers for Sepsis
NCT04280354 ·Status: TERMINATED
-
Early Prediction of Sepsis by Using Metabolomics
NCT03996759 ·Status: UNKNOWN
-
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226 ·Status: RECRUITING
-
Platelet-associated Inflammation in Severe Sepsis
NCT03029039 ·Status: COMPLETED